Patients with hepatitis B in two South American countries and Mexico
often go undiagnosed, are frequently undertreated, and usually rely on
government assistance to afford medication, according to a recent report
by Decision Resources.
Approximately 60% of 146 surveyed specialists, including
gastroenterologists, hepatologists and specialists in infectious disease
and internal medicine, indicated an increasing number of patients with
newly diagnosed HBV
during the previous 2 years. Many doctors also indicated, however, that
most HBV cases within Brazil, Argentina and Mexico go undiagnosed, and
many diagnosed patients do not receive adequate treatment.
Labels: access, disparities, epidemiology, Mexico, South America